SCHEMBL5065086

SCHEMBL5065086

Nc1nc(=O)[nH]cc1-c1ccoc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 1/20 0.44
CDK2 P24941 2/20 0.40
CCNT1 O60563 1/20 0.40
CCNA2 P20248 1/20 0.40
CDK9 P50750 1/20 0.40
CDK8 P49336 1/20 0.39
STK4 Q13043 1/20 0.39
STK3 Q13188 1/20 0.39
PLAU P00749 1/20 0.36
PDGFRB P09619 1/20 0.35
ADORA2A P29274 2/20 0.35
KDM5B Q9UGL1 1/20 0.34
CHEK1 O14757 1/20 0.33
ADORA1 P30542 3/20 0.33
TMIGD3 P0DMS9 1/20 0.33
PIM1 P11309 1/20 0.32
DYRK1A Q13627 1/20 0.32
DYRK2 Q92630 1/20 0.32
DYRK1B Q9Y463 1/20 0.32
CDC7 O00311 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3485241 0.76 PARP1 (0.47) CDK2DYRK1B
SCHEMBL7364095 0.74 IMPDH2 (0.42) IMPDH2CDK2CCNT1CCNA2CDK9
SCHEMBL5065232 0.71 ADORA1 (0.43) STK4STK3ADORA2AADORA1TMIGD3
SCHEMBL5069298 0.71 F2RL1 (0.30) IMPDH2
SCHEMBL21223675 0.70 CYP1A2 (0.42) IMPDH2CDK2PLAUADORA2AADORA1
SCHEMBL4915150 0.70 MAPT (0.42)
SCHEMBL4562986 0.69 MAP4K4 (0.47) CDK2CCNT1CCNA2CDK9STK4
SCHEMBL4563349 0.69 XDH (0.51) CDK2CCNT1CCNA2CDK9CDK8
SCHEMBL4563321 0.69 DHFR (0.54) STK4STK3ADORA2ACHEK1ADORA1
SCHEMBL6103621 0.68 ALDH1A1 (0.58) IMPDH2CDK2CDK8STK4STK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080261823-A1 Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-10-23 US claimed
WO-2006076102-A2 FLUORESCENT NUCLEOSIDE ANALOGS THAT MIMIC NATURALLY OCCURRING NUCLEOSIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-07-20 WO claimed
US-20080261823-A1 Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-10-23 US disclosed
WO-2006076102-A2 FLUORESCENT NUCLEOSIDE ANALOGS THAT MIMIC NATURALLY OCCURRING NUCLEOSIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080261823-A1 Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides NSUN2, NSUN3, NCL IMPDH2 143/4885CDK2 1842/4885CCNT1 1093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.